Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Adenocarcinoma × Resistance Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 26 Breast Neoplasms 20 Neoplasms 14 Prostatic Neoplasms 10 Obesity 7 Colorectal Neoplasms 6 Pancreatic Neoplasms 5 Sarcopenia 4 Polycystic Ovary Syndrome 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Multiple Myeloma 3 Lymphedema 3 Fatigue 3 Colonic Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Signs and Symptoms 2 Pharyngeal Neoplasms 2 Overweight 2 Lymphoma 2 Leukemia 2 Laryngeal Neoplasms 2 Insulin Resistance 2 Inflammation 2 Endometrial Neoplasms 2 Diabetes Mellitus, Type 2 2 Cachexia 2 Weight Loss 1 Uterine Neoplasms 1

Interventions

Gemcitabine 8 Albumin-Bound Paclitaxel 6 Taxes 4 Radiotherapy, Intensity-Modulated 3 130-nm albumin-bound paclitaxel 3 Radiotherapy 2 Fluorouracil 2 niraparib 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 dehydroftorafur 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Panitumumab 1 Oxaliplatin 1 Optical Imaging 1 Nivolumab 1 Metformin 1 Losartan 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Interleukin 1 Receptor Antagonist Protein 1 Folfox protocol 1 Ethiodized Oil 1 Electronic Health Records 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02680990 2018-02-28

REACT

Milton S. Hershey Medical Center

Phase NA Completed

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡